Correlation Between Templeton Developing and Franklin Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Templeton Developing and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Templeton Developing and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Templeton Developing Markets and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Templeton Developing and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Templeton Developing with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Templeton Developing and Franklin Biotechnology.

Diversification Opportunities for Templeton Developing and Franklin Biotechnology

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Templeton and Franklin is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Templeton Developing Markets and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Templeton Developing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Templeton Developing Markets are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Templeton Developing i.e., Templeton Developing and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Templeton Developing and Franklin Biotechnology

Assuming the 90 days horizon Templeton Developing is expected to generate 36.94 times less return on investment than Franklin Biotechnology. But when comparing it to its historical volatility, Templeton Developing Markets is 2.39 times less risky than Franklin Biotechnology. It trades about 0.01 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  14,358  in Franklin Biotechnology Discovery on September 19, 2024 and sell it today you would earn a total of  386.00  from holding Franklin Biotechnology Discovery or generate 2.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Templeton Developing Markets  vs.  Franklin Biotechnology Discove

 Performance 
       Timeline  
Templeton Developing 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Templeton Developing Markets has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong primary indicators, Templeton Developing is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Templeton Developing and Franklin Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Templeton Developing and Franklin Biotechnology

The main advantage of trading using opposite Templeton Developing and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Templeton Developing position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.
The idea behind Templeton Developing Markets and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk